DAY ONE BIOPHARMACEUTICALS I (DAWN) Institutional Ownership

DAWN is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $27.81M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $27.81M in its March 31, 2026 13F filing.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks asset manager ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward DAY ONE BIOPHARMACEUTICALS I (DAWN).